Industry Stakeholder forum on behalf of the UK AMR Diagnostics Collaborative

5th December 2018, London

NHS ENGLAND.jpg

 Hosted by NHS England on behalf of the UK AMR Diagnostic Collaborative

Overview

Following on from the successful UK AMR Diagnostics Collaborative (UKADC) Launch event in July 2018, the UKADC in responding to feedback and comments received are pleased to announce a forthcoming Forum & Workshop for Industry Stakeholders involved in Point of Care Diagnostics to address Antimicrobial Resistance within the UK. 

The UKADC is delighted to offer this opportunity to Industry discuss the current challenges and opportunities they envisage for accelerating the role of Point of Care Diagnostics and AMR within the UK. 

The event will take place on December 5th 2018 at The Wellcome Collection in London from  08.45-14.00pm. This industry focused stakeholder event will provide an opportunity for organisations to learn more about the goals of the UKADC whilst sharing ideas, suggestions and thoughts on how the Collaborative can drive forward POC Diagnostics for AMR to address the global challenge of Antimicrobial Resistance.

The aims of this event are to:

  • Work collaboratively and interactively to understand the current challenges faced when accelerating usage of solutions manufactured by industry

  • Capture the challenges and potential solutions to feed into national policy or framework for rapid point of care diagnostics in primary and secondary healthcare settings

  • Highlight opportunities for test bed working

  • Deliver these findings to system partners to assess industry versus system partners perspective of the AMR rapid diagnostics landscape


Venue

The launch will be held at the Wellcome Collection, London

Address:   183 Euston Road, London NW1 2BE

How to get there

By bicycle

We have five Sheffield cycle stands near the front entrance to Wellcome Collection on Euston Road and three stands to the side of the building on Gordon Street. Please be aware that bicycles are left at the owner's risk. There are Santander docking stations in front of Wellcome Collection on Euston Road and behind the building on Gower Place. Further docking stations can be found ne

By car/coach

By car/coach We have limited car parking space for blue badge holders only. More info. Wellcome Collection cannot accommodate coaches, so you will need to make your own parking arrangements if you are planning on bringing a group by coach. Please refer to TfL guidance for coaches. Please see our group visits page if you are planning to bring a group of eight or more people to visit Well.
 

Agenda

Industry Stakeholder forum on behalf of the UK AMR Diagnostics Collaborative

5th December 2018, London

09.30am-10am- Refreshments & Registration

10.00am-10.10am Welcome to the Forum

Speaker- Fiona Carragher, Deputy Chief Scientific Officer & Chair UKADC

10.10am-10.20am- Overview of the day, including:

·         How the session will work

·         Why the UKADC is hosting this event

·         Expectations and outcomes

Speaker- Scott Buckler, Director, 4 All of Us

10.20am-10.35am- Introducing the UKADC and its goals

Speaker- Fiona Carragher, Deputy Chief Scientific Officer & Chair UKADC

10.35am-10.55am- Developing a Test Bed for POC Diagnostics and why we need you!

Speaker- Russ Watkins, Assistant Director – Business Innovation & Improvement,The Newcastle upon Tyne Hospitals NHS Foundation Trust

10.55am-11.30am- Reflecting on the current challenges you are facing

This session will explore barriers Industry facing via a group exercise led by Scott Buckler, areas to include

·         Regulatory Environment

·         Quality and safety

·         Smart purchasing

·         Nimble adoption

·         Decommissioning

11.30am-12.00pm- Sharing the challenge

Three Industry representatives to present on market challenges they have faced

  1. Barriers to Introducing an Antimicrobial Stewardship Biomarker into the Hospital Environment

The increasing threat of AMR calls for more effective approaches to reduce both the prolonged and often unnecessary use of antibiotics.   Conventional diagnostic tests have suboptimal sensitivity and specificity, the ambiguity of which means that Healthcare professionals are often unclear on the need for antibiotics leading directly to overuse.

BRAHMS Procalcitonin is recommended in the Global Surviving Sepsis Guidelines for antimicrobial stewardship, the test is used routinely across Europe.  Despite many centres in the UK adopting the test, widespread adoption is slow and I plan to discuss some of the barriers we’ve faced introducing the test across the NHS

Speaker- Ross Stevenson, New Product & Business Development Manager at Thermo Fisher Scientific

2. Near patient testing (NPT) uptake barriers

Near patient testing (NPT) uptake and specifically CRP testing continues to be slow in Primary Care. Although there is a serious drive to reduce antibiotic prescribing, as an aid to tackling AMR, by national government and at CCG level, funding for NPT IVD’s has not followed this initiative, in addition to which there are several other issues such as clinical governance which prevent uptake. Having had several years’ experience marketing and selling to primary care and recently with a focus on CRP I plan to share my experiences of the barriers to the uptake of IVD’s in primary care in order to raise some of the issues as a basis for discussion around this topic.

Speaker- David Watwood, Director UK Professional Diagnostics, CIGA Healthcare

3. Barriers to funding Rapid Diagnostics implementation to tackle Antimicrobial Resistance

This presentation will address the funding challenges facing potential adopters of Rapid Diagnostic Technology within the healthcare field. NHS providers have multiple priorities which often dictate their activities and do not allow them to implement rapid diagnostics. In this presentation Roche Diagnostics will address these priorities in the context of a  'Real-Life' scenario in which the particular common barrier of  funding has prevented adoption of Rapid Diagnostics.

Speaker- Ajay Chauhan, Point of Care, Marketing Manager, Roche Diagnostics

12.00pm-12.35pm- Refreshments & Lunch

12.35pm-1.30pm- How do we accelerate Diagnostics usage, What does Diagnostic Policy look like to industry?

Interactive session on thought leadership, pathway development to accelerate diagnostics usage across the AMR landscape for POCT diagnostics, topics include:

·         Regulatory Environment

·         Quality and safety

·         Smart purchasing

·         Nimble adoption

·         Decommissioning

1.30pm- 1.45pm Commissioning for care pathways  – the role of diagnostics

Speaker- Kathleen Frost, Interim Programme Manager, DA Diagnostics and Pathology Programme, NWL CCG Collaboration

1.45pm- 2pm- Summary discussion

Speaker- Fiona Carragher, Deputy Chief Scientific Officer, NHS England

  • Agenda subject to change


Speakers

Fiona Carragher, Deputy Chief Scientific Officer & Chair UKADC

Russ Watkins, Assistant Director – Business Innovation & Improvement,The Newcastle upon Tyne Hospitals NHS Foundation Trust

Kathleen Frost, Interim Programme Manager, DA Diagnostics and Pathology Programme, NWL CCG Collaboration

Scott Buckler, Director, 4 All of Us

Tickets now closed

Check out the UK Diagnostics Summit on November 8th in London at www.ukdiagnosticssummit.com and join the debate